1.
Cao Z, Sui E, Wu Y. Behavior and Consequences of COVID-19-related Voluntary Disclosure: Evidence from Pharmaceutical Companies. BCPBM. 2022;31:378-391. doi:10.54691/bcpbm.v31i.2653